{"count": 66, "results": [{"_id": "33729072", "pmid": 33729072, "pmcid": "PMC7996084", "title": "Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy", "journal": "Drug Deliv", "authors": ["Song M", "Xia W", "Tao Z", "Zhu B", "Zhang W", "Liu C", "Chen S"], "date": "2021-12-01T00:00:00Z", "doi": "10.1080/10717544.2021.1898703", "meta_date_publication": "2021 Dec", "meta_volume": "28", "meta_issue": "1", "meta_pages": "594-606", "score": 50270.715, "text_hl": "Self-assembled polymeric nanocarrier-mediated co-delivery of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@ for @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@melanoma@@@ therapy", "citations": {"NLM": "Song M, Xia W, Tao Z, Zhu B, Zhang W, Liu C, Chen S. Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy Drug Deliv. 2021 Dec;28(1):594-606. PMID: 33729072", "BibTeX": "@article{33729072, title={Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy}, author={Song M and Xia W and Tao Z and Zhu B and Zhang W and Liu C and Chen S}, journal={Drug Deliv}, volume={28}, number={1}, pages={594-606}}"}}, {"_id": "34880915", "pmid": 34880915, "pmcid": "PMC8648459", "title": "Metformin Increases Sensitivity of Melanoma Cells to Cisplatin by Blocking Exosomal-Mediated miR-34a Secretion", "journal": "J Oncol", "authors": ["Ge L", "Wu Y", "Wan M", "You Y", "Zhai Z", "Song Z"], "date": "2021-11-29T00:00:00Z", "doi": "10.1155/2021/5525231", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "5525231", "score": 50264.93, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Increases Sensitivity of @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@Melanoma@@@ Cells to @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@Cisplatin@@@ by Blocking Exosomal-Mediated @GENE_MIR34A @GENE_407040 @@@miR-34a@@@ Secretion", "citations": {"NLM": "Ge L, Wu Y, Wan M, You Y, Zhai Z, Song Z. Metformin Increases Sensitivity of Melanoma Cells to Cisplatin by Blocking Exosomal-Mediated miR-34a Secretion J Oncol. 2021;2021():5525231. PMID: 34880915", "BibTeX": "@article{34880915, title={Metformin Increases Sensitivity of Melanoma Cells to Cisplatin by Blocking Exosomal-Mediated miR-34a Secretion}, author={Ge L and Wu Y and Wan M and You Y and Zhai Z and Song Z}, journal={J Oncol}, volume={2021}, pages={5525231}}"}}, {"_id": "36689538", "pmid": 36689538, "title": "Patients with melanoma and diabetes benefit from metformin treatment.", "journal": "Br J Dermatol", "date": "2023-01-23T00:00:00Z", "doi": "10.1093/bjd/ljac150", "meta_date_publication": "2023 Jan 23", "meta_volume": "188", "meta_issue": "1", "meta_pages": "e5", "score": 50262.75, "text_hl": "@SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@melanoma@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ benefit from @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment.", "citations": {"NLM": "Patients with melanoma and diabetes benefit from metformin treatment. Br J Dermatol. 2023 Jan 23;188(1):e5. PMID: 36689538", "BibTeX": "@article{36689538, title={Patients with melanoma and diabetes benefit from metformin treatment.}, journal={Br J Dermatol}, volume={188}, number={1}, pages={e5}}"}}, {"_id": "32980534", "pmid": 32980534, "title": "The impact of metformin on survival in patients with melanoma-national cohort study.", "journal": "Ann Epidemiol", "authors": ["Urbonas V", "Rutenberge J", "Patasius A", "Dulskas A", "Burokiene N", "Smailyte G"], "date": "2020-12-01T00:00:00Z", "doi": "10.1016/j.annepidem.2020.09.010", "meta_date_publication": "2020 Dec", "meta_volume": "52", "meta_issue": "", "meta_pages": "23-25", "score": 50262.676, "text_hl": "The impact of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on survival in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@melanoma@@@-national cohort study.", "citations": {"NLM": "Urbonas V, Rutenberge J, Patasius A, Dulskas A, Burokiene N, Smailyte G. The impact of metformin on survival in patients with melanoma-national cohort study. Ann Epidemiol. 2020 Dec;52():23-25. PMID: 32980534", "BibTeX": "@article{32980534, title={The impact of metformin on survival in patients with melanoma-national cohort study.}, author={Urbonas V and Rutenberge J and Patasius A and Dulskas A and Burokiene N and Smailyte G}, journal={Ann Epidemiol}, volume={52}, pages={23-25}}"}}, {"_id": "34386644", "pmid": 34386644, "pmcid": "PMC8328479", "title": "Antitumor Effect of Metformin in Combination with Binimetinib on Melanoma Cells", "journal": "Dev Reprod", "authors": ["Lee E", "Kwon Y", "Kim J", "Park D", "Lee Y"], "date": "2021-06-01T00:00:00Z", "doi": "10.12717/DR.2021.25.2.93", "meta_date_publication": "2021 Jun", "meta_volume": "25", "meta_issue": "2", "meta_pages": "93-104", "score": 50262.676, "text_hl": "Antitumor Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in Combination with @CHEMICAL_binimetinib @CHEMICAL_MESH:C581313 @@@Binimetinib@@@ on @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@Melanoma@@@ Cells", "citations": {"NLM": "Lee E, Kwon Y, Kim J, Park D, Lee Y. Antitumor Effect of Metformin in Combination with Binimetinib on Melanoma Cells Dev Reprod. 2021 Jun;25(2):93-104. PMID: 34386644", "BibTeX": "@article{34386644, title={Antitumor Effect of Metformin in Combination with Binimetinib on Melanoma Cells}, author={Lee E and Kwon Y and Kim J and Park D and Lee Y}, journal={Dev Reprod}, volume={25}, number={2}, pages={93-104}}"}}, {"_id": "32425881", "pmid": 32425881, "pmcid": "PMC7212476", "title": "Metformin and Its Benefits for Various Diseases", "journal": "Front Endocrinol (Lausanne)", "authors": ["Lv Z", "Guo Y"], "date": "2020-04-16T00:00:00Z", "doi": "10.3389/fendo.2020.00191", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "191", "score": 50261.133, "text_hl": "It will be interesting to investigate the effects of combination treatment of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with current therapies or other drugs to treat @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@melanoma@@@.", "citations": {"NLM": "Lv Z, Guo Y. Metformin and Its Benefits for Various Diseases Front Endocrinol (Lausanne). 2020;11():191. PMID: 32425881", "BibTeX": "@article{32425881, title={Metformin and Its Benefits for Various Diseases}, author={Lv Z and Guo Y}, journal={Front Endocrinol (Lausanne)}, volume={11}, pages={191}}"}}, {"_id": "34506671", "pmid": 34506671, "title": "Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance.", "journal": "Cell Biol Int", "authors": ["Sanches LJ", "Marinello PC", "da Silva Brito WA", "Lopes NMD", "Luiz RC", "Cecchini R", "Cecchini AL"], "date": "2022-01-01T00:00:00Z", "doi": "10.1002/cbin.11700", "meta_date_publication": "2022 Jan", "meta_volume": "46", "meta_issue": "1", "meta_pages": "73-82", "score": 50259.016, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ pretreatment reduces effect to @CHEMICAL_Dacarbazine @CHEMICAL_MESH:D003606 @@@dacarbazine@@@ and suppresses @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@melanoma@@@ cell resistance.", "citations": {"NLM": "Sanches LJ, Marinello PC, da Silva Brito WA, Lopes NMD, Luiz RC, Cecchini R, Cecchini AL. Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance. Cell Biol Int. 2022 Jan;46(1):73-82. PMID: 34506671", "BibTeX": "@article{34506671, title={Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance.}, author={Sanches LJ and Marinello PC and da Silva Brito WA and Lopes NMD and Luiz RC and Cecchini R and Cecchini AL}, journal={Cell Biol Int}, volume={46}, number={1}, pages={73-82}}"}}, {"_id": "33749049", "pmid": 33749049, "title": "Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.", "journal": "Oncologist", "authors": ["Novik AV", "Protsenko SA", "Baldueva IA", "Berstein LM", "Anisimov VN", "Zhuk IN", "Semenova AI", "Latipova DK", "Tkachenko EV", "Semiglazova TY"], "date": "2021-05-01T00:00:00Z", "doi": "10.1002/onco.13761", "meta_date_publication": "2021 May", "meta_volume": "26", "meta_issue": "5", "meta_pages": "364-e734", "score": 50258.848, "text_hl": "@CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@Melatonin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Failed to Modify the Effect of @CHEMICAL_Dacarbazine @CHEMICAL_MESH:D003606 @@@Dacarbazine@@@ in @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@Melanoma@@@.", "citations": {"NLM": "Novik AV, Protsenko SA, Baldueva IA, Berstein LM, Anisimov VN, Zhuk IN, Semenova AI, Latipova DK, Tkachenko EV, Semiglazova TY. Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma. Oncologist. 2021 May;26(5):364-e734. PMID: 33749049", "BibTeX": "@article{33749049, title={Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.}, author={Novik AV and Protsenko SA and Baldueva IA and Berstein LM and Anisimov VN and Zhuk IN and Semenova AI and Latipova DK and Tkachenko EV and Semiglazova TY}, journal={Oncologist}, volume={26}, number={5}, pages={364-e734}}"}}, {"_id": "32781368", "pmid": 32781368, "pmcid": "PMC7417947", "title": "Glucose 6-phosphate dehydrogenase inhibition sensitizes melanoma cells to metformin treatment", "journal": "Transl Oncol", "authors": ["Arbe MF", "Agnetti L", "Breininger E", "Glikin GC", "Finocchiaro LME", "Villaverde MS"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.tranon.2020.100842", "meta_date_publication": "2020 Nov", "meta_volume": "13", "meta_issue": "11", "meta_pages": "100842", "score": 50257.434, "text_hl": "@GENE_G6PD @GENE_2539 @@@Glucose 6-phosphate dehydrogenase@@@ inhibition sensitizes @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@melanoma@@@ cells to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment", "citations": {"NLM": "Arbe MF, Agnetti L, Breininger E, Glikin GC, Finocchiaro LME, Villaverde MS. Glucose 6-phosphate dehydrogenase inhibition sensitizes melanoma cells to metformin treatment Transl Oncol. 2020 Nov;13(11):100842. PMID: 32781368", "BibTeX": "@article{32781368, title={Glucose 6-phosphate dehydrogenase inhibition sensitizes melanoma cells to metformin treatment}, author={Arbe MF and Agnetti L and Breininger E and Glikin GC and Finocchiaro LME and Villaverde MS}, journal={Transl Oncol}, volume={13}, number={11}, pages={100842}}"}}, {"_id": "37397389", "pmid": 37397389, "pmcid": "PMC10312386", "title": "Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study", "journal": "Front Oncol", "authors": ["Augustin RC", "Huang Z", "Ding F", "Zhai S", "McArdle J", "Santisi A", "Davis M", "Sander C", "Davar D", "Kirkwood JM", "Delgoffe GM", "Warner AB", "Najjar YG"], "date": "2023-06-16T00:00:00Z", "doi": "10.3389/fonc.2023.1075823", "meta_date_publication": "2023", "meta_volume": "13", "meta_issue": "", "meta_pages": "1075823", "score": 50257.29, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is associated with improved clinical outcomes in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Melanoma</m> @DISEASE_MESH:D008545 @@@melanoma@@@: a retrospective, multi-institutional study", "citations": {"NLM": "Augustin RC, Huang Z, Ding F, Zhai S, McArdle J, Santisi A, Davis M, Sander C, Davar D, Kirkwood JM, Delgoffe GM, Warner AB, Najjar YG. Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study Front Oncol. 2023;13():1075823. PMID: 37397389", "BibTeX": "@article{37397389, title={Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study}, author={Augustin RC and Huang Z and Ding F and Zhai S and McArdle J and Santisi A and Davis M and Sander C and Davar D and Kirkwood JM and Delgoffe GM and Warner AB and Najjar YG}, journal={Front Oncol}, volume={13}, pages={1075823}}"}}]}